［1］ OAKNIN A,BOSSE TJ,CREUTZBERG CL,et al.Endometrial cancer:ESMO clinical practice guideline for diagnosis,treatment and follow-up ［J］.Annals of Oncology,2022,33(9):860-877.
［2］ BANZ-JANSEN C,HELWEG LP,KALTSCHMIDT B.Endometrial cancer stem cells:where do we stand and where should we go［J］.International Journal of Molecular Sciences,2022,23(6):23063412.
［3］ CHI Y,WANG D,WANG J,et al.Long non-coding RNA in the pathogenesis of cancers ［J］.Cells,2019,8(9):8091015.
［4］ SCHMITZ SU,GROTE P,HERRMANN BG.Mechanisms of long noncoding RNA function in development and disease ［J］.Cellular and Molecular Life Sciences,2016,73(13):2491-2509.
［5］ XING C,SUN SG,YUE ZQ,et al.Role of lncRNA LUCAT1 in cancer ［J］.Biomedicine & Pharmacotherapy,2021,134:111158.
［6］ WALAVALKAR K,NOTANI D.Beyond the coding genome:non-coding mutations and cancer ［J］.Frontiers in Bioscience (Landmark edition),2020,25(10):1828-1838.
［7］ LI L,CHEN P,HUANG B,et al.lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p ［J］.Oncol Lett,2021,22(6):825.
［8］ ZHANG L,WAN Y,ZHANG Z,et al.IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression ［J］.Theranostics,2021,11(3):1100-1114.
［9］ WANG J,LEI C,SHI P,et al.LncRNA DCST1-AS1 promotes endometrial cancer progression by modulating the miR-665/HOXB5 and miR-873-5p/CADM1 pathways ［J］.Front Oncol,2021,11:714652.
［10］ KE J,SHEN Z,HU W,et al.LncRNA DCST1-AS1 was upregulated in endometrial carcinoma and may sponge miR-92a-3p to upregulate Notch1 ［J］.Cancer Manag Res,2020,12:1221-1227.
［11］ ZHANG C,WANG R,LI M,et al.Long non-coding RNA BLACAT2/miR-378a-3p/YY1 feedback loop promotes the proliferation,migration and invasion of uterine corpus endometrial carcinoma ［J］.Oncology Reports,2023,49(5):8544.
［12］ DONG P,XIONG Y,YUE J,et al.Exploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment:advances and challenges ［J］.Cancers (Basel),2019,11(2):11020234.
［13］ MOU J,WANG B,LIU Y,et al.FER1L4:A long non-coding RNA with multiple roles in the occurrence and development of tumors ［J］.Curr Pharm Des,2022,28(16):1334-1341.
［14］ GUO C,SONG WQ,SUN P,et al.LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells ［J］.Journal of Biomedical Science,2015,22:100.
［15］ BIENKIEWICZ J,ROMANOWICZ H,SZYMANSKA B,et al.Analysis of lncRNA sequences:FAM3D-AS1,LINC01230,LINC01315 and LINC01468 in endometrial cancer ［J］.BMC Cancer,2022,22(1):343.
［16］ FAN JT,ZHOU ZY,LUO YL,et al.Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway ［J］.Neoplasia,2021,23(7):692-703.
［17］ LAI T,QIU H,SI L,et al.Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway ［J］.Cell Cycle,2022,21(15):1599-1618.
［18］ FAN L,WANG C,ZHAN P,et al.LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR-27b in endometrial carcinoma ［J］.Journal of Ovarian Research,2023,16(1):147.
［19］ MA J,KONG FF,YANG D,et al.lncRNA miR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway ［J］.Molecular Therapy Nucleic Acids,2021,24:905-922.
［20］ GAO Q,HUANG Q,LI F,et al.LncRNA MCTP1-AS1 regulates EMT process in endometrial cancer by targeting the miR-650/SMAD7 axis ［J］.OncoTargets and Therapy,2021,14:751-761.
［21］ FANG D,ZHANG Q,MU M,et al.lncRNA ENST00000585827 contributes to the progression of endometrial carcinoma via regulating miR-424/E2F6/E2F7 axis ［J］.Applied Biochemistry and Biotechnology,2023,195(5):3096-3108.
［22］ LI Y,HUO J,HE J,et al.LncRNA MONC suppresses the malignant phenotype of endometrial cancer stem cells and endometrial carcinoma cells by regulating the miR-636/GLCE axis ［J］.Cancer Cell Int,2021,21(1):331.
［23］ LI T,ZHOU S,YANG Y,et al.LncRNA MNX1-AS1:A novel oncogenic propellant in cancers ［J］.Biomed Pharmacother,2022,149:112801.
［24］ LIANG J,LIU C,XU D,et al.LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1 ［J］.Journal of Translational Medicine,2022,20(1):80.
［25］ GUO JL,TANG T,LI JH,et al.LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway ［J］.Pathol Oncol Res,2020,26(3):1757-1766.
［26］ LIN Z,FAN W,SUI X,et al.Necroptosis-related LncRNA signatures for prognostic prediction in uterine corpora endometrial cancer ［J］.Reproductive Sciences (Thousand Oaks,Calif),2023,30(2):576-589.
［27］ SHARMA Y,SAINI AK,KASHYAP S,et al.Host miRNA and immune cell interactions:relevance in nano-therapeutics for human health ［J］.Immunologic Research,2022,70(1):1-18.
［28］ VILLEGAS-MIRON P,GALLEGO A,BERTRANPETIT J,et al.Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks ［J］.Hum Genet,2022,141(10):1673-1693.
［29］ WANG Y,MA H,LI Y,et al.miR-192-5p-modified tumor-associated macrophages-derived exosome suppressed endometrial cancer progression through targeting IRAK1/NF-κB signaling ［J］.Reproductive Sciences (Thousand Oaks,Calif),2022,29(2):436-447.
［30］ WANG J,GONG X,YANG L,et al.Loss of exosomal miR-26a-5p contributes to endometrial cancer lymphangiogenesis and lymphatic metastasis ［J］.Clinical and Translational Medicine,2022,12(5):e846.
［31］ LIU Y,CHEN S,ZONG ZH,et al.CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer ［J］.J Cell Mol Med,2020,24(12):6898-6907.
［32］ PANG H,WANG J,WEI Q,et al.miR-548ag functions as an oncogene by suppressing MOB1B in the development of obesity-related endometrial cancer ［J］.Cancer Science,2023,114(4):1507-1518.
［33］ WANG P,ZHAO X,WU X,et al.miR-15b-3p promotes the malignant progression of endometrial cancer cells through targeting KLF2 ［J］.Cell Cycle,2021,20(14):1431-1440.
［34］ SUN X,HOU L,QIU C,et al.miR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer ［J］.Cellular & Molecular Biology Letters,2021,26(1):20.
［35］ LEE YS,DUTTA A.MicroRNAs in cancer ［J］.Annual Review of Pathology,2009,4:199-227.
［36］ WU Y,WANG F,SHI J,et al.CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis ［J］.Journal of Gynecologic Oncology,2023,34(2):e19.
［37］ MA J,ZHAO X,SHI L.Circ 003390/Eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p ［J］.Bioengineered,2022,13(5):11958-11972.
［38］ XIAO L,HE Y,PENG F,et al.Endometrial cancer cells promote M2-like macrophage polarization by delivering exosomal miRNA-21 under hypoxia condition ［J］.J Immunol Res,2020,2020:9731049.
［39］ JING L,HUA X,YUANNA D,et al.Exosomal miR-499a-5p inhibits endometrial cancer growth and metastasis via targeting VAV3 ［J］.Cancer Manag Res,2020,12:13541-13552.
［40］ CAI L,CHEN JJ,DENG FM,et al.miR-326 regulates the proliferation and apoptosis of endometrial cancer by targeting Bcl-2 ［J］.J Obstet Gynaecol Res,2021,47(2):621-630.
［41］ 饶珺,陈金玲,冯元元,等.miR-647通过靶基因NLRC5调控子宫内膜癌细胞的增殖和凋亡［J］.现代肿瘤医学，2022,30(17):3096-3101.
RAO Jun,CHEN Jinling,FENG Yuanyuan,et al.miR-647 regulates the proliferation and apoptosis of endometrial cancer cells through the target gene NLRC5［J］.Modern Oncology,2022,30(17):3096-3101.
［42］ WU C,ZHOU X,LI J,et al.Serum miRNA-204-5p as a potential non-invasive biomarker for the diagnosis of endometrial cancer with sentinel lymph node mapping ［J］.Oncol Lett,2022,24(2):248.
［43］ NI L,TANG C,WANG Y,et al.Construction of a miRNA-based nomogram model to predict the prognosis of endometrial cancer ［J］.Journal of Personalized Medicine,2022,12(7):1154.
［44］ GUZ M,JELENIEWICZ W,CYBULSKI M.An insight into miR-1290:An oncogenic miRNA with diagnostic potential ［J］.International Journal of Molecular Sciences,2022,23(3):1234.
［45］ LIZ J,PORTELA A,SOLER M,et al.Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region ［J］.Mol Cell,2014,55(1):138-147.
［46］ ZHANG Y,LUO M,CUI X,et al.Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA ［J］.Cell Death and Differentiation,2022,29(9):1850-1863.
［47］ ZHOU Y,SHAO Y,HU W,et al.A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3 ［J］.Cell Death and Differentiation,2023,30(1):111-124.
［48］ LIU YX,YUAN S,LIU XJ,et al.LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis ［J］.J Mol Med (Berl),2022,100(9):1271-1286.
［49］ SHEN L,WU Y,LI A,et al.LncRNA TTN-AS1 promotes endometrial cancer by sponging miR-376a-3p ［J］.Oncology Reports,2020,44(4):1343-1354.
［50］ YANG X,XING G,LIU S,et al.LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression ［J］.Biomed Pharmacother,2020,125:109839.
［51］ DONG P,XIONG Y,YUE J,et al.Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes ［J］.Journal of Experimental & Clinical Cancer Research:CR,2019,38(1):295.
［52］ CHEN Y,LI Z,CHEN X,et al.Long non-coding RNAs:From disease code to drug role ［J］.Acta Pharmaceutica Sinica B,2021,11(2):340-354.
［53］ FENG J,ZHANG J,LI Y,et al.Inhibition of lncRNA PCAT19 promotes breast cancer proliferation ［J］.Cancer Medicine,2023,12(10):11971-11982.
［54］ 翟媛媛,柴丽君,梁冰,等.lncRNA MRCCAT1在乳腺癌组织中的表达及对细胞增殖和侵袭的影响［J］.现代肿瘤医学，2021,29(24):4333-4337.
ZHAI Yuanyuan,CHAI Lijun,LIANG Bing,et al.Expression of lncRNA MRCCAT1 in breast cancer tissues and its effect on cell proliferation and invasiveness［J］.Modern Oncology,2021,29(24):4333-4337.